Alexandria Real Estate Equities, Inc. Highlights Its Role in Advancing Blood Cancer Innovation by Enabling Life-Changing Tenant R&D, Mission-Critical Philanthropic Initiatives and Strategic Invest
Go back to Alexandria Real Estate Equities, Inc. Highlights Its Role in Advancing Blood Cancer Innovation by Enabling Life-Changing Tenant R&D, Mission-Critical Philanthropic Initiatives and Strategic Invest| ALEXANDRIA RE EQUITIES (NYSE: ARE) | Delayed: 50.34 -0.43 (0.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.77 | 52 Week High | $114.67 | |||
| Open | $50.74 | 52 Week Low | $70.69 | |||
| Day High | $51.03 | P/E | 33.34 | |||
| Day Low | $50.01 | EPS | $1.51 | |||
| Volume | 1,016,851 | |||||
